Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Mitsuya S, Tsuruoka K, Kanaoka K, Funamoto T, et al. Comparison Between Second- and Third-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as First-line Treatment in Patients With Non-small-cell Lung Cancer: A Retrospective Analysis. Anticancer Res 2021;41:5137-5145.
PMID: 34593465


Privacy Policy